Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Brian A. Ference, Henry N. Ginsberg, Ian Graham, Kausik K. Ray, Chris J. Packard, Eric Bruckert, Robert A. Hegele, Ronald M. Krauss, Frederick J. Raal, Heribert Schunkert, Gerald F. Watts, Jan Boren, Sergio Fazio, Jay D. Horton, Luis Masana, Stephen J. Nicholls, Borge G. Nordestgaard, Bart van de Sluis, Marja-Riitta Taskinen, Lale TokgözogluUlf Landmesser, Ulrich Laufs, Olov Wiklund, Jane K. Stock, M. John Chapman, Alberico L. Catapano

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Heart Journal
Volume38
Issue number32
Pages (from-to)2459-2472
Number of pages14
ISSN0195-668X
DOIs
Publication statusPublished - 21 Aug 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Atherosclerosis
  • Cardiovascular disease
  • Low-density lipoprotein
  • Mendelian randomization
  • Clinical trials
  • Statin
  • Ezetimibe
  • PCSK9
  • Causality
  • Recommendations
  • CORONARY-HEART-DISEASE
  • HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
  • CHOLESTEROL-FED RABBITS
  • STATIN THERAPY
  • MENDELIAN RANDOMIZATION
  • LDL CHOLESTEROL
  • GENERAL-POPULATION
  • RISK
  • METAANALYSIS
  • TRIAL
  • 3121 Internal medicine

Cite this